Michael E. Weisser, P.C.

Kirkland & Ellis advised private equity firm Altas Partners on a strategic partnership with claims management provider Sedgwick. The transaction was announced September 12, 2024 and is expected to close in the fourth quarter of 2024, subject to customary closing conditions. Current investors, including funds managed by global investment firm Carlyle and by Stone Point Capital LLC, will remain as investors and continue to make significant new investments in the business, with Carlyle maintaining its control position in partnership with the investor group and the Sedgwick management team. Altas has committed to invest $1 billion of equity as part of the transaction. This transaction implies a total enterprise value of approximately $13.2 billion. Read the transaction press release The Kirkland team was led by corporate partners Keri Schick Norton, Michael Weisser, Aidan Murphy and Shawn OHargan.

Sep 12

1 min

Kirkland & Ellis is advising Patient Square, a dedicated health investment firm, on the $4.1 billion acquisition of Patterson Companies, Inc. (Nasdaq: PDCO), a leading dental and animal health distributor. A definitive agreement was announced December 11, 2024, and the transaction is expected to close in the fourth quarter of Patterson’s fiscal 2025, subject to the receipt of shareholder approval, regulatory approvals and customary closing conditions. Under the terms of the agreement, Patterson shareholders will receive $31.35 in cash per share, representing an approximately 49% premium to Patterson’s 30 calendar day volume-weighted average price ending December 4, 2024 (the last trading day prior to Patterson announcing the evaluation of strategic alternatives). Read the transaction press release The Kirkland team included corporate lawyers Maggie Flores, Michael Weisser and Oliver Yee; debt finance lawyers John Ilardo, Jason Kanner and Joel Weinberger; capital markets lawyers Julia Danforth and Sophia Hudson; and tax lawyer Mark Schwed.

Dec 11

1 min

Kirkland & Ellis advised health care investment firm Patient Square Capital on a definitive agreement for a strategic partnership with CorroHealth, a revenue cycle management provider for health systems and health plans. The transaction was announced October 24, 2024. Current shareholders, including investment funds affiliated with global investment firm Carlyle (NASDAQ: CG), TT Capital Partners, Sanaka Group, and CorroHealth management, will remain investors, with Patient Square and Carlyle sharing joint control of CorroHealth. The transaction is expected to close by the end of the year. Read the transaction press release The Kirkland team included corporate lawyers Michael Weisser, Christopher Burwell and Aseda Ghartey-Tagoe; debt finance lawyers Jason Kanner and Bridget Hahn; tax lawyers Mark Schwed and Matthew Wahlquist; and executive compensation lawyer Rohit Nafday.

Oct 25

1 min

Kirkland & Ellis advised global alternative asset management firm TPG on a majority investment in Surescripts, the nation’s leading health information network. The transaction was announced October 1, 2024. TPG is investing in Surescripts through TPG Capital, the firm’s U.S. and European private equity platform. The investment will allow Surescripts to develop an array of solutions addressing healthcare’s biggest challenges and accelerate Surescripts’ ability to scale existing Intelligent Prescribing, Benefits and Authorizations, and Clinical Interoperability solutions. The transaction is subject to customary regulatory approvals. Read the transaction press release The Kirkland team was led by corporate partners Michael Weisser, Maggie Flores and Zach Miller; antitrust & competition partner Matt Reilly; tax partners Jared Rusman and Bill Dong; executive compensation partners Stephen Jacobson and Alison Beskin; and technology & IP transactions partners Seth Traxler and Shellie Freedman.

Oct 2

1 min

Kirkland & Ellis advised Patient Square Capital on the sale of its remaining interest in Radius Health to B‑FLEXION Life Sciences. Patient Square and B-FLEXION originally acquired Radius in August 2022 through a take‑private transaction. The transaction was announced January 12, 2026 and is expected to close by the end of the first quarter of 2026. Read the transaction press release The Kirkland team included corporate lawyers Maggie Flores, Michael Weisser and Zach Miller; and tax lawyer Mark Schwed.

Jan 14

1 min